Literature DB >> 23595635

Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study.

Cheol Min Shin1, Nayoung Kim, Hye Seung Lee, Ji Hyun Park, Soyeon Ahn, Gyeong Hoon Kang, Jung Mogg Kim, Joo Sung Kim, Dong Ho Lee, Hyun Chae Jung.   

Abstract

Changes of DNA methylation in gastric mucosae after eradication of Helicobacter pylori have not been clarified yet. From this background, we investigated time course of DNA methylation following H. pylori eradication in 221 successfully H. pylori eradicated subjects with endoscopic follow-up at least for 6 months, including 114 controls, 53 subjects with gastric dysplasia and 54 patients with early gastric cancer. All dysplasia and gastric cancer patients underwent endoscopic resection at the time of enrollment. The methylation levels in LOX, APC and MOS genes from noncancerous gastric mucosae using quantitative methylation-specific PCR, as well as the histologic findings of gastric mucosae, were compared before and after eradication. Average follow-up duration was 26.0 months (range: 6 to 76 months). H. pylori eradication decreased methylation levels in LOX (p-value for slope < 0.001) but not in APC. In MOS, decrease of its methylation level following H. pylori eradication was significant among controls without intestinal metaplasia (IM) (p-value for slope < 0.05); however, it was not observed among patients with IM or those with dysplasia or gastric cancer. After H. pylori eradication, methylation level in MOS persistently increased in patients with dysplasia or gastric cancer (p < 0.01). In conclusion, H. pylori eradication decreases aberrant DNA methylation with gene-specific manner. Methylation level in MOS is associated with IM and may be used as a surrogate marker for gastric cancer risk, regardless of H. pylori eradication history.
© 2013 UICC.

Entities:  

Keywords:  Helicobacter pylori; gastric cancer; inflammation; methylation

Mesh:

Substances:

Year:  2013        PMID: 23595635     DOI: 10.1002/ijc.28219

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

Review 1.  Cancer-promoting effects of microbial dysbiosis.

Authors:  Amy M Sheflin; Alyssa K Whitney; Tiffany L Weir
Journal:  Curr Oncol Rep       Date:  2014-10       Impact factor: 5.075

Review 2.  Pathogens hijack the epigenome: a new twist on host-pathogen interactions.

Authors:  Natalie C Silmon de Monerri; Kami Kim
Journal:  Am J Pathol       Date:  2014-02-11       Impact factor: 4.307

3.  Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication.

Authors:  Masahiro Maeda; Satoshi Yamashita; Taichi Shimazu; Naoko Iida; Hideyuki Takeshima; Takeshi Nakajima; Ichiro Oda; Sohachi Nanjo; Chika Kusano; Akiko Mori; Hiroshi Moro; Harumi Yamada; Shoichiro Tsugane; Toshiro Sugiyama; Yoshiharu Sakai; Toshikazu Ushijima
Journal:  Gastric Cancer       Date:  2018-02-09       Impact factor: 7.370

Review 4.  Gastric cancer development after the successful eradication of Helicobacter pylori.

Authors:  Kaname Uno; Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

5.  Helicobacter pylori-induced modulation of the promoter methylation of Wnt antagonist genes in gastric carcinogenesis.

Authors:  Hyo-Joon Yang; Sang Gyun Kim; Joo Hyun Lim; Ji Min Choi; Woo Ho Kim; Hyun Chae Jung
Journal:  Gastric Cancer       Date:  2017-06-22       Impact factor: 7.370

6.  Somatic DNA Hypomethylation in H. pylori-Associated High-Risk Gastritis and Gastric Cancer: Enhanced Somatic Hypomethylation Associates with Advanced Stage Cancer.

Authors:  Andreas Leodolter; Sergio Alonso; Beatriz González; Matthias P Ebert; Michael Vieth; Christoph Röcken; Thomas Wex; Ullrich Peitz; Peter Malfertheiner; Manuel Perucho
Journal:  Clin Transl Gastroenterol       Date:  2015-04-30       Impact factor: 4.488

Review 7.  The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review.

Authors:  Wei Zeng; Jinfeng Zhu; Li Shan; Zhigang Han; Patiguli Aerxiding; Amina Quhai; Fanye Zeng; Ziwei Wang; Huiwu Li
Journal:  Drug Des Devel Ther       Date:  2015-04-13       Impact factor: 4.162

8.  Risk Factors for Metachronous Gastric Neoplasms in Patients Who Underwent Endoscopic Resection of a Gastric Neoplasm.

Authors:  Hyuk Yoon; Nayoung Kim; Cheol Min Shin; Hye Seung Lee; Bo Kyoung Kim; Gyeong Hoon Kang; Jung Mogg Kim; Joo Sung Kim; Dong Ho Lee; Hyun Chae Jung
Journal:  Gut Liver       Date:  2016-03       Impact factor: 4.519

9.  Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial.

Authors:  Maki Kawanaka; Jiro Watari; Noriko Kamiya; Takahisa Yamasaki; Takashi Kondo; Fumihiko Toyoshima; Hisatomo Ikehara; Toshihiko Tomita; Tadayuki Oshima; Hirokazu Fukui; Takashi Daimon; Kiron M Das; Hiroto Miwa
Journal:  Br J Cancer       Date:  2015-12-15       Impact factor: 7.640

10.  BARHL2 Methylation Using Gastric Wash DNA or Gastric Juice Exosomal DNA is a Useful Marker For Early Detection of Gastric Cancer in an H. pylori-Independent Manner.

Authors:  Hiroyuki Yamamoto; Yoshiyuki Watanabe; Ritsuko Oikawa; Ryo Morita; Yoshihito Yoshida; Tadateru Maehata; Hiroshi Yasuda; Fumio Itoh
Journal:  Clin Transl Gastroenterol       Date:  2016-07-21       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.